nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Parotitis—Etoposide—lung cancer	0.0957	0.126	CcSEcCtD
Trihexyphenidyl—Sinus bradycardia—Crizotinib—lung cancer	0.0436	0.0576	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Vinblastine—lung cancer	0.028	0.0369	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Vinorelbine—lung cancer	0.0232	0.0307	CcSEcCtD
Trihexyphenidyl—Cognitive impairment—Methotrexate—lung cancer	0.0158	0.0209	CcSEcCtD
Trihexyphenidyl—Ileus paralytic—Paclitaxel—lung cancer	0.0156	0.0206	CcSEcCtD
Trihexyphenidyl—Sinus bradycardia—Paclitaxel—lung cancer	0.0138	0.0182	CcSEcCtD
Trihexyphenidyl—Blindness—Cisplatin—lung cancer	0.0136	0.0179	CcSEcCtD
Trihexyphenidyl—Dry skin—Gefitinib—lung cancer	0.0129	0.0171	CcSEcCtD
Trihexyphenidyl—Weight decreased—Crizotinib—lung cancer	0.0121	0.016	CcSEcCtD
Trihexyphenidyl—Weight decreased—Gefitinib—lung cancer	0.011	0.0146	CcSEcCtD
Trihexyphenidyl—Cognitive disorder—Methotrexate—lung cancer	0.00955	0.0126	CcSEcCtD
Trihexyphenidyl—Vision blurred—Crizotinib—lung cancer	0.00882	0.0116	CcSEcCtD
Trihexyphenidyl—Dry skin—Erlotinib—lung cancer	0.00773	0.0102	CcSEcCtD
Trihexyphenidyl—Weight decreased—Erlotinib—lung cancer	0.0066	0.00871	CcSEcCtD
Trihexyphenidyl—Constipation—Crizotinib—lung cancer	0.00653	0.00862	CcSEcCtD
Trihexyphenidyl—Blindness—Doxorubicin—lung cancer	0.00646	0.00852	CcSEcCtD
Trihexyphenidyl—Agitation—Teniposide—lung cancer	0.00637	0.0084	CcSEcCtD
Trihexyphenidyl—Constipation—Pemetrexed—lung cancer	0.00597	0.00788	CcSEcCtD
Trihexyphenidyl—Constipation—Gefitinib—lung cancer	0.00593	0.00783	CcSEcCtD
Trihexyphenidyl—Weight decreased—Vinorelbine—lung cancer	0.0057	0.00753	CcSEcCtD
Trihexyphenidyl—Confusional state—Teniposide—lung cancer	0.0057	0.00752	CcSEcCtD
Trihexyphenidyl—Tachycardia—Teniposide—lung cancer	0.00552	0.00728	CcSEcCtD
Trihexyphenidyl—Asthenia—Crizotinib—lung cancer	0.00548	0.00723	CcSEcCtD
Trihexyphenidyl—Dizziness—Crizotinib—lung cancer	0.00505	0.00667	CcSEcCtD
Trihexyphenidyl—Asthenia—Pemetrexed—lung cancer	0.00501	0.00661	CcSEcCtD
Trihexyphenidyl—Asthenia—Gefitinib—lung cancer	0.00498	0.00657	CcSEcCtD
Trihexyphenidyl—Vomiting—Crizotinib—lung cancer	0.00486	0.00641	CcSEcCtD
Trihexyphenidyl—Rash—Crizotinib—lung cancer	0.00482	0.00636	CcSEcCtD
Trihexyphenidyl—Dermatitis—Crizotinib—lung cancer	0.00481	0.00635	CcSEcCtD
Trihexyphenidyl—Weight decreased—Irinotecan—lung cancer	0.0047	0.00621	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Teniposide—lung cancer	0.00466	0.00615	CcSEcCtD
Trihexyphenidyl—Dizziness—Pemetrexed—lung cancer	0.00462	0.00609	CcSEcCtD
Trihexyphenidyl—Nausea—Crizotinib—lung cancer	0.00454	0.00599	CcSEcCtD
Trihexyphenidyl—Dry skin—Paclitaxel—lung cancer	0.0045	0.00593	CcSEcCtD
Trihexyphenidyl—Vomiting—Pemetrexed—lung cancer	0.00444	0.00586	CcSEcCtD
Trihexyphenidyl—Vomiting—Gefitinib—lung cancer	0.00441	0.00582	CcSEcCtD
Trihexyphenidyl—Rash—Pemetrexed—lung cancer	0.0044	0.00581	CcSEcCtD
Trihexyphenidyl—Dermatitis—Pemetrexed—lung cancer	0.0044	0.0058	CcSEcCtD
Trihexyphenidyl—Rash—Gefitinib—lung cancer	0.00437	0.00577	CcSEcCtD
Trihexyphenidyl—Dermatitis—Gefitinib—lung cancer	0.00437	0.00577	CcSEcCtD
Trihexyphenidyl—Nausea—Pemetrexed—lung cancer	0.00415	0.00547	CcSEcCtD
Trihexyphenidyl—Nausea—Gefitinib—lung cancer	0.00412	0.00544	CcSEcCtD
Trihexyphenidyl—Asthenia—Teniposide—lung cancer	0.00406	0.00535	CcSEcCtD
Trihexyphenidyl—Weight decreased—Paclitaxel—lung cancer	0.00384	0.00506	CcSEcCtD
Trihexyphenidyl—Dry skin—Docetaxel—lung cancer	0.00381	0.00503	CcSEcCtD
Trihexyphenidyl—Constipation—Vinblastine—lung cancer	0.00369	0.00487	CcSEcCtD
Trihexyphenidyl—Vomiting—Teniposide—lung cancer	0.00359	0.00474	CcSEcCtD
Trihexyphenidyl—Constipation—Topotecan—lung cancer	0.00358	0.00473	CcSEcCtD
Trihexyphenidyl—Rash—Teniposide—lung cancer	0.00356	0.0047	CcSEcCtD
Trihexyphenidyl—Dermatitis—Teniposide—lung cancer	0.00356	0.0047	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Vinblastine—lung cancer	0.00355	0.00469	CcSEcCtD
Trihexyphenidyl—Constipation—Erlotinib—lung cancer	0.00355	0.00468	CcSEcCtD
Trihexyphenidyl—Headache—Teniposide—lung cancer	0.00354	0.00467	CcSEcCtD
Trihexyphenidyl—Tachycardia—Vinorelbine—lung cancer	0.0035	0.00462	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Topotecan—lung cancer	0.00345	0.00456	CcSEcCtD
Trihexyphenidyl—Nausea—Teniposide—lung cancer	0.00336	0.00443	CcSEcCtD
Trihexyphenidyl—Weight decreased—Docetaxel—lung cancer	0.00325	0.00429	CcSEcCtD
Trihexyphenidyl—Vision blurred—Cisplatin—lung cancer	0.0031	0.00409	CcSEcCtD
Trihexyphenidyl—Asthenia—Vinblastine—lung cancer	0.00309	0.00408	CcSEcCtD
Trihexyphenidyl—Constipation—Vinorelbine—lung cancer	0.00307	0.00405	CcSEcCtD
Trihexyphenidyl—Asthenia—Topotecan—lung cancer	0.00301	0.00397	CcSEcCtD
Trihexyphenidyl—Confusional state—Irinotecan—lung cancer	0.00298	0.00393	CcSEcCtD
Trihexyphenidyl—Asthenia—Erlotinib—lung cancer	0.00297	0.00393	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Vinorelbine—lung cancer	0.00295	0.0039	CcSEcCtD
Trihexyphenidyl—Tension—Paclitaxel—lung cancer	0.0029	0.00383	CcSEcCtD
Trihexyphenidyl—Nervousness—Paclitaxel—lung cancer	0.00287	0.00379	CcSEcCtD
Trihexyphenidyl—Dizziness—Vinblastine—lung cancer	0.00285	0.00376	CcSEcCtD
Trihexyphenidyl—Vision blurred—Paclitaxel—lung cancer	0.00278	0.00367	CcSEcCtD
Trihexyphenidyl—Dizziness—Topotecan—lung cancer	0.00277	0.00366	CcSEcCtD
Trihexyphenidyl—Vomiting—Vinblastine—lung cancer	0.00274	0.00362	CcSEcCtD
Trihexyphenidyl—Dizziness—Erlotinib—lung cancer	0.00274	0.00362	CcSEcCtD
Trihexyphenidyl—Agitation—Paclitaxel—lung cancer	0.00271	0.00358	CcSEcCtD
Trihexyphenidyl—Headache—Vinblastine—lung cancer	0.0027	0.00357	CcSEcCtD
Trihexyphenidyl—Vomiting—Topotecan—lung cancer	0.00266	0.00352	CcSEcCtD
Trihexyphenidyl—Rash—Topotecan—lung cancer	0.00264	0.00349	CcSEcCtD
Trihexyphenidyl—Dermatitis—Topotecan—lung cancer	0.00264	0.00348	CcSEcCtD
Trihexyphenidyl—Vomiting—Erlotinib—lung cancer	0.00264	0.00348	CcSEcCtD
Trihexyphenidyl—Somnolence—Irinotecan—lung cancer	0.00263	0.00347	CcSEcCtD
Trihexyphenidyl—Headache—Topotecan—lung cancer	0.00262	0.00346	CcSEcCtD
Trihexyphenidyl—Tachycardia—Cisplatin—lung cancer	0.00262	0.00346	CcSEcCtD
Trihexyphenidyl—Rash—Erlotinib—lung cancer	0.00261	0.00345	CcSEcCtD
Trihexyphenidyl—Dermatitis—Erlotinib—lung cancer	0.00261	0.00345	CcSEcCtD
Trihexyphenidyl—Headache—Erlotinib—lung cancer	0.0026	0.00343	CcSEcCtD
Trihexyphenidyl—Asthenia—Vinorelbine—lung cancer	0.00257	0.00339	CcSEcCtD
Trihexyphenidyl—Nausea—Vinblastine—lung cancer	0.00256	0.00338	CcSEcCtD
Trihexyphenidyl—Somnolence—Gemcitabine—lung cancer	0.00256	0.00338	CcSEcCtD
Trihexyphenidyl—Constipation—Irinotecan—lung cancer	0.00253	0.00334	CcSEcCtD
Trihexyphenidyl—Nausea—Topotecan—lung cancer	0.00249	0.00329	CcSEcCtD
Trihexyphenidyl—Confusional state—Etoposide—lung cancer	0.00248	0.00327	CcSEcCtD
Trihexyphenidyl—Constipation—Gemcitabine—lung cancer	0.00246	0.00325	CcSEcCtD
Trihexyphenidyl—Nausea—Erlotinib—lung cancer	0.00246	0.00325	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Irinotecan—lung cancer	0.00244	0.00322	CcSEcCtD
Trihexyphenidyl—Confusional state—Paclitaxel—lung cancer	0.00243	0.00321	CcSEcCtD
Trihexyphenidyl—Tachycardia—Etoposide—lung cancer	0.0024	0.00317	CcSEcCtD
Trihexyphenidyl—Dry skin—Doxorubicin—lung cancer	0.00238	0.00314	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Gemcitabine—lung cancer	0.00237	0.00313	CcSEcCtD
Trihexyphenidyl—Dizziness—Vinorelbine—lung cancer	0.00237	0.00313	CcSEcCtD
Trihexyphenidyl—Tachycardia—Paclitaxel—lung cancer	0.00235	0.00311	CcSEcCtD
Trihexyphenidyl—Drowsiness—Methotrexate—lung cancer	0.00231	0.00305	CcSEcCtD
Trihexyphenidyl—Vomiting—Vinorelbine—lung cancer	0.00228	0.00301	CcSEcCtD
Trihexyphenidyl—Rash—Vinorelbine—lung cancer	0.00226	0.00298	CcSEcCtD
Trihexyphenidyl—Dermatitis—Vinorelbine—lung cancer	0.00226	0.00298	CcSEcCtD
Trihexyphenidyl—Headache—Vinorelbine—lung cancer	0.00225	0.00296	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Cisplatin—lung cancer	0.00221	0.00292	CcSEcCtD
Trihexyphenidyl—Somnolence—Etoposide—lung cancer	0.00219	0.00289	CcSEcCtD
Trihexyphenidyl—Somnolence—Paclitaxel—lung cancer	0.00214	0.00283	CcSEcCtD
Trihexyphenidyl—Nausea—Vinorelbine—lung cancer	0.00213	0.00281	CcSEcCtD
Trihexyphenidyl—Asthenia—Irinotecan—lung cancer	0.00212	0.0028	CcSEcCtD
Trihexyphenidyl—Constipation—Etoposide—lung cancer	0.0021	0.00278	CcSEcCtD
Trihexyphenidyl—Asthenia—Gemcitabine—lung cancer	0.00207	0.00273	CcSEcCtD
Trihexyphenidyl—Constipation—Paclitaxel—lung cancer	0.00206	0.00272	CcSEcCtD
Trihexyphenidyl—Confusional state—Docetaxel—lung cancer	0.00206	0.00272	CcSEcCtD
Trihexyphenidyl—Weight decreased—Doxorubicin—lung cancer	0.00203	0.00268	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Etoposide—lung cancer	0.00203	0.00267	CcSEcCtD
Trihexyphenidyl—Drowsiness—Doxorubicin—lung cancer	0.002	0.00264	CcSEcCtD
Trihexyphenidyl—Tachycardia—Docetaxel—lung cancer	0.00199	0.00263	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Paclitaxel—lung cancer	0.00199	0.00262	CcSEcCtD
Trihexyphenidyl—Dizziness—Irinotecan—lung cancer	0.00195	0.00258	CcSEcCtD
Trihexyphenidyl—Asthenia—Cisplatin—lung cancer	0.00193	0.00254	CcSEcCtD
Trihexyphenidyl—Vomiting—Irinotecan—lung cancer	0.00188	0.00248	CcSEcCtD
Trihexyphenidyl—Rash—Irinotecan—lung cancer	0.00186	0.00246	CcSEcCtD
Trihexyphenidyl—Dermatitis—Irinotecan—lung cancer	0.00186	0.00246	CcSEcCtD
Trihexyphenidyl—Headache—Irinotecan—lung cancer	0.00185	0.00244	CcSEcCtD
Trihexyphenidyl—Vomiting—Gemcitabine—lung cancer	0.00183	0.00242	CcSEcCtD
Trihexyphenidyl—Somnolence—Docetaxel—lung cancer	0.00182	0.0024	CcSEcCtD
Trihexyphenidyl—Rash—Gemcitabine—lung cancer	0.00182	0.0024	CcSEcCtD
Trihexyphenidyl—Dermatitis—Gemcitabine—lung cancer	0.00181	0.00239	CcSEcCtD
Trihexyphenidyl—Headache—Gemcitabine—lung cancer	0.0018	0.00238	CcSEcCtD
Trihexyphenidyl—Asthenia—Etoposide—lung cancer	0.00176	0.00233	CcSEcCtD
Trihexyphenidyl—Nausea—Irinotecan—lung cancer	0.00176	0.00232	CcSEcCtD
Trihexyphenidyl—Constipation—Docetaxel—lung cancer	0.00175	0.00231	CcSEcCtD
Trihexyphenidyl—Asthenia—Paclitaxel—lung cancer	0.00173	0.00228	CcSEcCtD
Trihexyphenidyl—Nausea—Gemcitabine—lung cancer	0.00171	0.00226	CcSEcCtD
Trihexyphenidyl—Vomiting—Cisplatin—lung cancer	0.00171	0.00225	CcSEcCtD
Trihexyphenidyl—Vision blurred—Methotrexate—lung cancer	0.0017	0.00224	CcSEcCtD
Trihexyphenidyl—Rash—Cisplatin—lung cancer	0.00169	0.00223	CcSEcCtD
Trihexyphenidyl—Dermatitis—Cisplatin—lung cancer	0.00169	0.00223	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Docetaxel—lung cancer	0.00168	0.00222	CcSEcCtD
Trihexyphenidyl—Dizziness—Etoposide—lung cancer	0.00163	0.00215	CcSEcCtD
Trihexyphenidyl—Dizziness—Paclitaxel—lung cancer	0.00159	0.0021	CcSEcCtD
Trihexyphenidyl—Nausea—Cisplatin—lung cancer	0.00159	0.0021	CcSEcCtD
Trihexyphenidyl—Vomiting—Etoposide—lung cancer	0.00156	0.00206	CcSEcCtD
Trihexyphenidyl—Rash—Etoposide—lung cancer	0.00155	0.00205	CcSEcCtD
Trihexyphenidyl—Dermatitis—Etoposide—lung cancer	0.00155	0.00204	CcSEcCtD
Trihexyphenidyl—Headache—Etoposide—lung cancer	0.00154	0.00203	CcSEcCtD
Trihexyphenidyl—Tension—Doxorubicin—lung cancer	0.00153	0.00202	CcSEcCtD
Trihexyphenidyl—Vomiting—Paclitaxel—lung cancer	0.00153	0.00202	CcSEcCtD
Trihexyphenidyl—Rash—Paclitaxel—lung cancer	0.00152	0.00201	CcSEcCtD
Trihexyphenidyl—Dermatitis—Paclitaxel—lung cancer	0.00152	0.002	CcSEcCtD
Trihexyphenidyl—Nervousness—Doxorubicin—lung cancer	0.00152	0.002	CcSEcCtD
Trihexyphenidyl—Headache—Paclitaxel—lung cancer	0.00151	0.00199	CcSEcCtD
Trihexyphenidyl—Confusional state—Methotrexate—lung cancer	0.00149	0.00196	CcSEcCtD
Trihexyphenidyl—Vision blurred—Doxorubicin—lung cancer	0.00147	0.00194	CcSEcCtD
Trihexyphenidyl—Asthenia—Docetaxel—lung cancer	0.00147	0.00194	CcSEcCtD
Trihexyphenidyl—Nausea—Etoposide—lung cancer	0.00146	0.00193	CcSEcCtD
Trihexyphenidyl—Agitation—Doxorubicin—lung cancer	0.00144	0.0019	CcSEcCtD
Trihexyphenidyl—Nausea—Paclitaxel—lung cancer	0.00143	0.00189	CcSEcCtD
Trihexyphenidyl—Dizziness—Docetaxel—lung cancer	0.00135	0.00178	CcSEcCtD
Trihexyphenidyl—Somnolence—Methotrexate—lung cancer	0.00131	0.00173	CcSEcCtD
Trihexyphenidyl—Vomiting—Docetaxel—lung cancer	0.0013	0.00171	CcSEcCtD
Trihexyphenidyl—Rash—Docetaxel—lung cancer	0.00129	0.0017	CcSEcCtD
Trihexyphenidyl—Dermatitis—Docetaxel—lung cancer	0.00129	0.0017	CcSEcCtD
Trihexyphenidyl—Confusional state—Doxorubicin—lung cancer	0.00129	0.0017	CcSEcCtD
Trihexyphenidyl—Headache—Docetaxel—lung cancer	0.00128	0.00169	CcSEcCtD
Trihexyphenidyl—Tachycardia—Doxorubicin—lung cancer	0.00124	0.00164	CcSEcCtD
Trihexyphenidyl—Nausea—Docetaxel—lung cancer	0.00121	0.0016	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Methotrexate—lung cancer	0.00121	0.0016	CcSEcCtD
Trihexyphenidyl—Somnolence—Doxorubicin—lung cancer	0.00113	0.0015	CcSEcCtD
Trihexyphenidyl—Constipation—Doxorubicin—lung cancer	0.00109	0.00144	CcSEcCtD
Trihexyphenidyl—Asthenia—Methotrexate—lung cancer	0.00106	0.00139	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Doxorubicin—lung cancer	0.00105	0.00139	CcSEcCtD
Trihexyphenidyl—Dizziness—Methotrexate—lung cancer	0.000974	0.00129	CcSEcCtD
Trihexyphenidyl—Vomiting—Methotrexate—lung cancer	0.000936	0.00124	CcSEcCtD
Trihexyphenidyl—Rash—Methotrexate—lung cancer	0.000929	0.00123	CcSEcCtD
Trihexyphenidyl—Dermatitis—Methotrexate—lung cancer	0.000928	0.00122	CcSEcCtD
Trihexyphenidyl—Headache—Methotrexate—lung cancer	0.000923	0.00122	CcSEcCtD
Trihexyphenidyl—Asthenia—Doxorubicin—lung cancer	0.000915	0.00121	CcSEcCtD
Trihexyphenidyl—Nausea—Methotrexate—lung cancer	0.000875	0.00115	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxorubicin—lung cancer	0.000843	0.00111	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxorubicin—lung cancer	0.000811	0.00107	CcSEcCtD
Trihexyphenidyl—Rash—Doxorubicin—lung cancer	0.000804	0.00106	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxorubicin—lung cancer	0.000803	0.00106	CcSEcCtD
Trihexyphenidyl—Headache—Doxorubicin—lung cancer	0.000799	0.00105	CcSEcCtD
Trihexyphenidyl—Nausea—Doxorubicin—lung cancer	0.000758	0.001	CcSEcCtD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—IL2—lung cancer	6.59e-05	0.000272	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EGFR—lung cancer	6.59e-05	0.000272	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	6.58e-05	0.000271	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—PIK3CA—lung cancer	6.57e-05	0.000271	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CB—lung cancer	6.52e-05	0.000269	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—KRAS—lung cancer	6.5e-05	0.000268	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAP2K1—lung cancer	6.4e-05	0.000264	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CD—lung cancer	6.35e-05	0.000262	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL8—lung cancer	6.34e-05	0.000262	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL8—lung cancer	6.32e-05	0.000261	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ERBB3—lung cancer	6.3e-05	0.00026	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—PIK3CA—lung cancer	6.29e-05	0.00026	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ERBB3—lung cancer	6.28e-05	0.000259	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL8—lung cancer	6.26e-05	0.000258	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ERBB3—lung cancer	6.22e-05	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—KRAS—lung cancer	6.22e-05	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CG—lung cancer	6.07e-05	0.00025	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL2—lung cancer	6.06e-05	0.00025	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL2—lung cancer	6.04e-05	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TERT—lung cancer	6.04e-05	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TERT—lung cancer	6.02e-05	0.000248	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL2—lung cancer	5.98e-05	0.000247	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PIK3CA—lung cancer	5.97e-05	0.000246	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TERT—lung cancer	5.96e-05	0.000246	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MDM2—lung cancer	5.94e-05	0.000245	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—RAF1—lung cancer	5.92e-05	0.000244	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGFR1—lung cancer	5.87e-05	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ERBB2—lung cancer	5.86e-05	0.000242	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGFR1—lung cancer	5.85e-05	0.000241	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGFR1—lung cancer	5.79e-05	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CB—lung cancer	5.78e-05	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MTOR—lung cancer	5.78e-05	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HIF1A—lung cancer	5.78e-05	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—POMC—lung cancer	5.78e-05	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HIF1A—lung cancer	5.76e-05	0.000238	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PIK3CA—lung cancer	5.72e-05	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HIF1A—lung cancer	5.7e-05	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MDM2—lung cancer	5.69e-05	0.000235	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—RAF1—lung cancer	5.67e-05	0.000234	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—CREBBP—lung cancer	5.63e-05	0.000232	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ERBB2—lung cancer	5.61e-05	0.000232	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOA1—lung cancer	5.57e-05	0.00023	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL8—lung cancer	5.56e-05	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOA1—lung cancer	5.56e-05	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MTOR—lung cancer	5.54e-05	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CB—lung cancer	5.54e-05	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KDR—lung cancer	5.52e-05	0.000228	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HRAS—lung cancer	5.52e-05	0.000228	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KDR—lung cancer	5.51e-05	0.000227	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOA1—lung cancer	5.5e-05	0.000227	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KDR—lung cancer	5.45e-05	0.000225	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AKT1—lung cancer	5.37e-05	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CD—lung cancer	5.33e-05	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL8—lung cancer	5.32e-05	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CASP3—lung cancer	5.32e-05	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL2—lung cancer	5.31e-05	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HRAS—lung cancer	5.29e-05	0.000218	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—lung cancer	5.29e-05	0.000218	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALB—lung cancer	5.27e-05	0.000217	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCND1—lung cancer	5.18e-05	0.000214	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—JUN—lung cancer	5.17e-05	0.000213	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AKT1—lung cancer	5.14e-05	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CASP3—lung cancer	5.09e-05	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CG—lung cancer	5.09e-05	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KIT—lung cancer	5.09e-05	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APC—lung cancer	5.09e-05	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—NRAS—lung cancer	5.09e-05	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL2—lung cancer	5.09e-05	0.00021	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APC—lung cancer	5.07e-05	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CG—lung cancer	5.07e-05	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KIT—lung cancer	5.07e-05	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—NRAS—lung cancer	5.07e-05	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—lung cancer	5.06e-05	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGF—lung cancer	5.03e-05	0.000208	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—lung cancer	5.03e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APC—lung cancer	5.02e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CG—lung cancer	5.02e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KIT—lung cancer	5.02e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—NRAS—lung cancer	5.02e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGF—lung cancer	5.01e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN1A—lung cancer	5.01e-05	0.000207	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PTEN—lung cancer	5e-05	0.000206	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGF—lung cancer	4.97e-05	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCND1—lung cancer	4.96e-05	0.000205	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—JUN—lung cancer	4.95e-05	0.000204	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AKT1—lung cancer	4.88e-05	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—MAPK3—lung cancer	4.87e-05	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—MAPK3—lung cancer	4.86e-05	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—POMC—lung cancer	4.84e-05	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—POMC—lung cancer	4.83e-05	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—lung cancer	4.81e-05	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—MAPK3—lung cancer	4.81e-05	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN1A—lung cancer	4.8e-05	0.000198	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PTEN—lung cancer	4.79e-05	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—BRAF—lung cancer	4.78e-05	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—POMC—lung cancer	4.78e-05	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—BRAF—lung cancer	4.77e-05	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EP300—lung cancer	4.77e-05	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6R—lung cancer	4.73e-05	0.000195	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—BRAF—lung cancer	4.72e-05	0.000195	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CREBBP—lung cancer	4.72e-05	0.000195	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6R—lung cancer	4.71e-05	0.000194	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CREBBP—lung cancer	4.7e-05	0.000194	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AKT1—lung cancer	4.67e-05	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6R—lung cancer	4.67e-05	0.000192	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CREBBP—lung cancer	4.66e-05	0.000192	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CB—lung cancer	4.65e-05	0.000192	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—lung cancer	4.64e-05	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SRC—lung cancer	4.63e-05	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—lung cancer	4.62e-05	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—lung cancer	4.61e-05	0.00019	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—lung cancer	4.58e-05	0.000189	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EP300—lung cancer	4.56e-05	0.000188	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—lung cancer	4.51e-05	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAP2K1—lung cancer	4.5e-05	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAP2K1—lung cancer	4.49e-05	0.000185	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CD—lung cancer	4.47e-05	0.000185	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—STAT3—lung cancer	4.47e-05	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CD—lung cancer	4.46e-05	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NRAS—lung cancer	4.46e-05	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAP2K1—lung cancer	4.45e-05	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SRC—lung cancer	4.44e-05	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	4.43e-05	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	4.42e-05	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CD—lung cancer	4.42e-05	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—KRAS—lung cancer	4.38e-05	0.000181	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CA—lung cancer	4.37e-05	0.00018	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—KRAS—lung cancer	4.37e-05	0.00018	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—KRAS—lung cancer	4.32e-05	0.000178	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—lung cancer	4.32e-05	0.000178	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—STAT3—lung cancer	4.28e-05	0.000177	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK3—lung cancer	4.27e-05	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NRAS—lung cancer	4.27e-05	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MYC—lung cancer	4.15e-05	0.000171	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK3—lung cancer	4.09e-05	0.000169	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—lung cancer	4.06e-05	0.000168	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	4.02e-05	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTEN—lung cancer	4.02e-05	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	4.01e-05	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MDM2—lung cancer	4.01e-05	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MDM2—lung cancer	4e-05	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RAF1—lung cancer	3.99e-05	0.000165	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RAF1—lung cancer	3.98e-05	0.000164	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MYC—lung cancer	3.98e-05	0.000164	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CA—lung cancer	3.97e-05	0.000164	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MDM2—lung cancer	3.96e-05	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ERBB2—lung cancer	3.95e-05	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RAF1—lung cancer	3.94e-05	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ERBB2—lung cancer	3.94e-05	0.000163	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ERBB2—lung cancer	3.9e-05	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CB—lung cancer	3.9e-05	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MTOR—lung cancer	3.9e-05	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—lung cancer	3.89e-05	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MTOR—lung cancer	3.89e-05	0.00016	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CB—lung cancer	3.89e-05	0.00016	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MTOR—lung cancer	3.85e-05	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CB—lung cancer	3.85e-05	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KRAS—lung cancer	3.84e-05	0.000158	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—EP300—lung cancer	3.83e-05	0.000158	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL8—lung cancer	3.75e-05	0.000155	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL8—lung cancer	3.74e-05	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HRAS—lung cancer	3.72e-05	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HRAS—lung cancer	3.71e-05	0.000153	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL8—lung cancer	3.7e-05	0.000153	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HRAS—lung cancer	3.68e-05	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KRAS—lung cancer	3.68e-05	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AKT1—lung cancer	3.62e-05	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AKT1—lung cancer	3.61e-05	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CASP3—lung cancer	3.59e-05	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL2—lung cancer	3.58e-05	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CASP3—lung cancer	3.58e-05	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AKT1—lung cancer	3.57e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL2—lung cancer	3.57e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—lung cancer	3.56e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—lung cancer	3.55e-05	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CASP3—lung cancer	3.54e-05	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL2—lung cancer	3.54e-05	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CA—lung cancer	3.53e-05	0.000145	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—lung cancer	3.52e-05	0.000145	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCND1—lung cancer	3.49e-05	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—JUN—lung cancer	3.48e-05	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCND1—lung cancer	3.48e-05	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—JUN—lung cancer	3.47e-05	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCND1—lung cancer	3.45e-05	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—JUN—lung cancer	3.44e-05	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—lung cancer	3.41e-05	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—lung cancer	3.39e-05	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—lung cancer	3.38e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN1A—lung cancer	3.38e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CA—lung cancer	3.38e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTEN—lung cancer	3.37e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN1A—lung cancer	3.37e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTEN—lung cancer	3.36e-05	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—lung cancer	3.35e-05	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN1A—lung cancer	3.33e-05	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTEN—lung cancer	3.33e-05	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AKT1—lung cancer	3.29e-05	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AKT1—lung cancer	3.28e-05	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—lung cancer	3.27e-05	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HRAS—lung cancer	3.26e-05	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AKT1—lung cancer	3.25e-05	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EP300—lung cancer	3.21e-05	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EP300—lung cancer	3.2e-05	0.000132	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EP300—lung cancer	3.17e-05	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SRC—lung cancer	3.13e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HRAS—lung cancer	3.12e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—lung cancer	3.12e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SRC—lung cancer	3.12e-05	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SRC—lung cancer	3.08e-05	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—lung cancer	3.04e-05	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—lung cancer	3.03e-05	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STAT3—lung cancer	3.01e-05	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NRAS—lung cancer	3.01e-05	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—lung cancer	3e-05	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STAT3—lung cancer	3e-05	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NRAS—lung cancer	3e-05	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—lung cancer	2.99e-05	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STAT3—lung cancer	2.98e-05	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NRAS—lung cancer	2.97e-05	0.000122	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AKT1—lung cancer	2.88e-05	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK3—lung cancer	2.88e-05	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK3—lung cancer	2.87e-05	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK3—lung cancer	2.84e-05	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CA—lung cancer	2.83e-05	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MYC—lung cancer	2.8e-05	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MYC—lung cancer	2.79e-05	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MYC—lung cancer	2.76e-05	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AKT1—lung cancer	2.76e-05	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—lung cancer	2.74e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—lung cancer	2.73e-05	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—lung cancer	2.7e-05	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KRAS—lung cancer	2.59e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KRAS—lung cancer	2.58e-05	0.000106	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KRAS—lung cancer	2.55e-05	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CA—lung cancer	2.38e-05	9.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CA—lung cancer	2.37e-05	9.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CA—lung cancer	2.35e-05	9.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AKT1—lung cancer	2.32e-05	9.55e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—lung cancer	2.3e-05	9.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—lung cancer	2.29e-05	9.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—lung cancer	2.27e-05	9.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HRAS—lung cancer	2.2e-05	9.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HRAS—lung cancer	2.19e-05	9.05e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HRAS—lung cancer	2.17e-05	8.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—lung cancer	2.11e-05	8.69e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—lung cancer	2.1e-05	8.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—lung cancer	2.08e-05	8.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT1—lung cancer	1.94e-05	8.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT1—lung cancer	1.94e-05	7.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT1—lung cancer	1.92e-05	7.91e-05	CbGpPWpGaD
